Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study
World Journal of Urology · 2024
DOI: 10.1007/s00345-024-05000-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Urology, 2024. Verfasst von Gregor Duwe und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Pediatric Urology, University Medical Center Johannes Gutenberg University, Langenbeckstrasse 1, 55131, Mainz, Germany. gre…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Image-Guided Biopsy, Multiparametric Magnetic Resonance Imaging. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsmedizin der Johannes Gutenberg-Universität Mainz.
Abstract (Originalsprache)
Purpose
The goal of this study is to address if detection rates of clinically significant prostate cancer (csPCa) can be increased by additional perilesional biopsies (PB) in magnetic resonance (MR)/ultrasound fusion prostate biopsy in biopsy-naïve men.
Methods
This prospective, non-randomized, surgeon-blinded study was conducted between February 2020 and July 2022. Patients were included with PSA levels < 20 ng/ml and ≥ one PI-RADS lesion (grades 3–5) per prostate lobe. Prostate biopsy was performed by two urologists. The first performed the MR-fusion biopsy with 3–5 targeted biopsies (TB) and 6 PB in a standardized pattern. The second performed the systematic (12-fold) biopsy (SB) without knowledge of the MR images. Primary outcome of this study is absence or presence of csPCa (≥ ISUP grade 2) comparing TB, PB and SB, using McNemar test.
Results
Analyses were performed for each PI-RADS lesion (n = 218). There was a statistically significant difference in csPC detection rate of TB + SB between PI-RADS 3, 4 and 5 lesions (18.0% vs. 42.5% vs. 82.6%, p < 0.001) and TB + PB (19.7% vs. 29.1% vs. 78.3%). Comparing only maximum ISUP grade per lesion, even SB plus TB plus PB did not detect more csPCa compared to SB plus TB (41.3% vs. 39.9%, p > 0.05).
Conclusion
We present prospective study data investigating the role of perilesional biopsy in detection of prostate cancer. We detected no statistically significant difference in the detection of csPCa by the addition of PB. Therefore, we recommend continuing 12-fold bilateral SB in addition to TB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology and Pediatric Urology, University Medical Center Johannes Gutenberg University, Langenbeckstrasse 1, 55131, Mainz, Germany. gregor.duwe@unimedizin-mainz.de.
- Department of Urology and Pediatric Urology, University Medical Center Johannes Gutenberg University, Langenbeckstrasse 1, 55131, Mainz, Germany.
- Department of Urology, University Hospital and Faculty of Medicine Eberhard Karls University, Tübingen, Germany.
- Department of Urology, University Hospital Carl Gustav-Carus, TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
- Department of Urology, Ordensklinikum Linz Elisabethinen, Fadinger Strasse 1, 4020, Linz, Austria.
Förderung
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Zitieren
APA
Duwe, G., Schmitteckert, M., Haack, M., Sparwasser, P., Dotzauer, R., Thomas, A., Tsaur, I., Brandt, M. P., Kurosch, M., Mager, R., Haferkamp, A., Boehm, K., & Höfner, T. (2024). Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study. World Journal of Urology. https://doi.org/10.1007/s00345-024-05000-6
Vancouver
Duwe G, Schmitteckert M, Haack M, Sparwasser P, Dotzauer R, Thomas A, et al. Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study. World Journal of Urology. 2024. doi:10.1007/s00345-024-05000-6
BibTeX
@article{Duwe2024,
author = {Duwe, Gregor and Schmitteckert, Melanie and Haack, Maximilian and Sparwasser, Peter and Dotzauer, Robert and Thomas, Anita and Tsaur, Igor and Brandt, Maximilian Peter and Kurosch, Martin and Mager, Rene and Haferkamp, Axel and Boehm, Katharina and Höfner, Thomas},
title = {Value of perilesional biopsies in multiparametric magnetic resonance imaging-targeted biopsy and systematic biopsy in detection of prostate cancer: results of a prospective, non-randomized, surgeon-blinded study},
journal = {World Journal of Urology},
year = {2024},
doi = {10.1007/s00345-024-05000-6}
}
EUVIMED